Display options
Cite
Topic A, Ljujic M, Radojkovic D. Alpha-1-antitrypsin in pathogenesis of hepatocellular carcinoma. Hepat Mon. 2012;12(10):e7042doi: 10.5812/hepatmon.7042.
Topic, A., Ljujic, M., & Radojkovic, D. (2012). Alpha-1-antitrypsin in pathogenesis of hepatocellular carcinoma. Hepatitis monthly, 12(10), e7042. https://doi.org/10.5812/hepatmon.7042
Topic, Aleksandra, et al. "Alpha-1-antitrypsin in pathogenesis of hepatocellular carcinoma." Hepatitis monthly vol. 12,10 (2012): e7042. doi: https://doi.org/10.5812/hepatmon.7042
Topic A, Ljujic M, Radojkovic D. Alpha-1-antitrypsin in pathogenesis of hepatocellular carcinoma. Hepat Mon. 2012 Oct;12(10):e7042. doi: 10.5812/hepatmon.7042. Epub 2012 Oct 30. PMID: 23162602; PMCID: PMC3496874.
Copy Download .nbib Format: NLM
Share it on

Hepat Mon. 2012 Oct;12(10):e7042. doi: 10.5812/hepatmon.7042. Epub 2012 Oct 30.

Alpha-1-antitrypsin in pathogenesis of hepatocellular carcinoma.

Hepatitis monthly

Aleksandra Topic, Mila Ljujic, Dragica Radojkovic

Affiliations

  1. University of Belgrade, Faculty of Pharmacy, Department of Medical Biochemistry, Belgrade, Serbia.

PMID: 23162602 PMCID: PMC3496874 DOI: 10.5812/hepatmon.7042

Abstract

CONTEXT: Alpha-1-antitrypsin (A1AT) is the most abundant liver-derived, highly polymorphic, glycoprotein in plasma. Hereditary deficiency of alpha-1-antitrypsin in plasma (A1ATD) is a consequence of accumulation of polymers of A1AT mutants in endoplasmic reticulum of hepatocytes and other A1AT-producing cells. One of the clinical manifestations of A1ATD is liver disease in childhood and cirrhosis and/or hepatocellular carcinoma (HCC) in adulthood. Epidemiology and pathophysiology of liver failure in early childhood caused by A1ATD are well known, but the association with hepatocellular carcinoma is not clarified. The aim of this article is to review different aspects of association between A1AT variants and hepatocellular carcinoma, with emphasis on the epidemiology and molecular pathogenesis. The significance of A1AT as a biomarker in the diagnosis of HCC is also discussed.

EVIDENCE ACQUISITIONS: Search for relevant articles were performed through Pub Med, HighWire, and Science Direct using the keywords "alpha-1-antitrypsin", "liver diseases", "hepatocellular carcinoma", "SERPINA1". Articles published until 2011 were reviewed.

RESULTS: Epidemiology studies revealed that severe A1ATD is a significant risk factor for cirrhosis and HCC unrelated to the presence of HBV or HCV infections. However, predisposition to HCC in moderate A1ATD is rare, and probably happens in combination with HBV and/or HCV infections or other unknown risk factors. It is assumed that accumulation of polymers of A1ATD variants in endoplasmic reticulum of hepatocytes leads to damage of hepatocytes by gain-of-function mechanism. Also, increased level of A1AT was recognized as diagnostic and prognostic marker of HCC.

CONCLUSIONS: Clarification of a carcinogenic role for A1ATD and identification of proinflammatory or some still unknown factors that lead to increased susceptibility to HCC associated with A1ATD may contribute to a better understanding of hepatic carcinogenesis and to the development of new drugs.

Keywords: Alpha 1-Antitrypsin Deficiency; Autophagy; Carcinoma, Hepatocellular; Fucose

References

  1. J Biol Chem. 2005 Nov 25;280(47):39002-15 - PubMed
  2. Acta Hepatogastroenterol (Stuttg). 1976 Apr;23(2):114-7 - PubMed
  3. Virchows Arch A Pathol Anat Histol. 1982;397(2):163-70 - PubMed
  4. Cancer. 1979 Feb;43(2):596-604 - PubMed
  5. J Immunol. 2010 Apr 15;184(8):4538-46 - PubMed
  6. Hepatology. 1981 Nov-Dec;1(6):628-31 - PubMed
  7. J Biol Chem. 1996 Sep 13;271(37):22791-5 - PubMed
  8. Gastroenterol Clin Biol. 1985 Dec;9(12):881-5 - PubMed
  9. Gastroenterology. 1987 Aug;93(2):242-4 - PubMed
  10. Br J Cancer. 1990 Jan;61(1):72-3 - PubMed
  11. Am J Hum Genet. 1985 Sep;37(5):868-72 - PubMed
  12. Gene. 2011 Dec 10;489(2):98-102 - PubMed
  13. Am J Physiol Gastrointest Liver Physiol. 2002 Nov;283(5):G1156-65 - PubMed
  14. Pathology. 1985 Oct;17(4):649-52 - PubMed
  15. Hepatology. 2005 Sep;42(3):514-21 - PubMed
  16. Cancer Lett. 1995 Feb 10;89(1):15-21 - PubMed
  17. Acta Med Scand. 1974 Jun;195(6):451-8 - PubMed
  18. Hepatology. 2006 Oct;44(4):857-64 - PubMed
  19. Br J Cancer. 1978 Apr;37(4):635-8 - PubMed
  20. Int J Biochem Cell Biol. 2008;40(8):1403-14 - PubMed
  21. Hepatology. 1984 Mar-Apr;4(2):235-41 - PubMed
  22. J Clin Pathol. 1985 May;38(5):588-92 - PubMed
  23. Biochim Biophys Acta. 2005 Jun 10;1740(3):390-402 - PubMed
  24. J Clin Invest. 1989 Apr;83(4):1183-90 - PubMed
  25. Hepatol Res. 2010 Jun;40(6):641-53 - PubMed
  26. Arch Pathol Lab Med. 1976 May;100(5):232-6 - PubMed
  27. J Hepatol. 1994 Dec;21(6):1006-11 - PubMed
  28. N Engl J Med. 2002 Jan 3;346(1):45-53 - PubMed
  29. FEBS Lett. 1986 Sep 15;205(2):255-60 - PubMed
  30. Clin Gastroenterol Hepatol. 2005 Apr;3(4):390-6 - PubMed
  31. N Engl J Med. 1981 Mar 5;304(10):557-60 - PubMed
  32. Ann Intern Med. 1974 Dec;81(6):771-3 - PubMed
  33. Am J Physiol Gastrointest Liver Physiol. 2004 May;286(5):G851-62 - PubMed
  34. Mol Biol Cell. 2006 Jan;17(1):203-12 - PubMed
  35. Clin Chim Acta. 1992 Mar 31;206(3):225-30 - PubMed
  36. Protein Sci. 2000 Jul;9(7):1274-81 - PubMed
  37. Hum Pathol. 1979 Jul;10(4):419-24 - PubMed
  38. Clin Chem. 2001 Aug;47(8):1490-6 - PubMed
  39. Nature. 1992 Jun 18;357(6379):605-7 - PubMed
  40. N Engl J Med. 1986 Mar 20;314(12):736-9 - PubMed
  41. Aliment Pharmacol Ther. 2011 Feb;33(3):389-94 - PubMed
  42. J Clin Invest. 2002 Dec;110(11):1579-83 - PubMed
  43. Hepatology. 1992 Mar;15(3):407-10 - PubMed
  44. Hum Genet. 1990 Jan;84(2):132-6 - PubMed
  45. PLoS One. 2010 Aug 25;5(8):e12419 - PubMed
  46. Mol Med Rep. 2010 Jul-Aug;3(4):589-96 - PubMed
  47. Br J Cancer. 1987 Sep;56(3):371-5 - PubMed
  48. BMC Gastroenterol. 2010 Feb 20;10:22 - PubMed
  49. Ann Intern Med. 1992 Oct 15;117(8):641-5 - PubMed
  50. Q J Med. 1976 Apr;45(178):B51-72 - PubMed
  51. Eur Cytokine Netw. 1991 Mar-Apr;2(2):89-98 - PubMed
  52. J Pediatr Gastroenterol Nutr. 2006 Jul;43 Suppl 1:S30-5 - PubMed
  53. J Neurosurg. 1987 Aug;67(2):258-62 - PubMed
  54. Hepatology. 1998 Oct;28(4):1058-63 - PubMed
  55. J Hepatol. 2000 Dec;33(6):883-92 - PubMed
  56. Dig Dis Sci. 1987 Dec;32(12):1358-62 - PubMed
  57. Am J Clin Pathol. 1975 Sep;64(3):304-10 - PubMed
  58. Arch Med Res. 2008 Feb;39(2):236-41 - PubMed
  59. J Korean Med Sci. 1991 Sep;6(3):206-13 - PubMed
  60. J Biol Chem. 1993 Jul 25;268(21):15333-5 - PubMed
  61. Chest. 2005 Oct;128(4):2076-81 - PubMed
  62. Cancer. 2000 Jun 15;88(12):2668-76 - PubMed
  63. N Engl J Med. 1972 Dec 21;287(25):1264-7 - PubMed
  64. Am J Med. 1978 Dec;65(6):978-86 - PubMed
  65. J Gastroenterol Hepatol. 1999 May;14(5):436-45 - PubMed
  66. Eur J Cancer. 1996 Feb;32A(2):221-5 - PubMed
  67. Acta Med Scand. 1987;221(5):461-7 - PubMed
  68. Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1914-21 - PubMed
  69. Z Gastroenterol. 2010 Oct;48(10):1211-4 - PubMed
  70. Science. 2010 Jul 9;329(5988):229-32 - PubMed
  71. Ned Tijdschr Geneeskd. 2000 Nov 18;144(47):2269-72 - PubMed
  72. Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):9014-8 - PubMed
  73. Am J Gastroenterol. 1997 Apr;92(4):602-7 - PubMed
  74. Am J Physiol Gastrointest Liver Physiol. 2000 Nov;279(5):G961-74 - PubMed
  75. Eur J Gastroenterol Hepatol. 1996 Oct;8(10):989-94 - PubMed
  76. Best Pract Res Clin Gastroenterol. 2005 Feb;19(1):101-18 - PubMed

Publication Types